The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...
The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...
A bill filed Thursday (Jan. 16) in the Arkansas Legislature would prohibit pharmacy benefit managers and insurance companies ...
Pharmacy advocate groups are teaming up with lawmakers to get new legislation passed to stop monopolistic behaviors from ...
The Arkansas Pharmacists Association is calling for public and legislative support for stronger regulation of Pharmacy ...
Prescription drug prices are rising, and a new report from the Federal Trade Commission (FTC) explains why. Pharmacy benefit ...
On January 13, 2025, the Federal Trade Commission announced that it is seeking comment on proposed changes to the Business ...
Lina Khan chaired what was likely the final open commission meeting of her time as chair of the Federal Trade Commission (FTC) and ...
UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...
In an investor call, Andrew Witty promised full transparency and 100% pass-through rebates for prescription drugs by 2028.
FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...
The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds or thousands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback